DD DuPont
Q2 2025 10-Q
Filed: Aug 5, 2025Period ending Jun 30, 2025
Health Care
Plastic Materials, Synth Resins & Nonvulcan ElastomersSEC EDGAR DuPont (DD) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Aug 5, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ2 2025 10-Q
Management Discussion & Analysis
- • Cash flow from operations $763M, down 25.2% vs $1,020M in H1 2024; driven by working capital changes and separation costs
- • Cash and equivalents $1.8B vs $1.9B Dec ’24; total debt stable at $7.175B vs $7.171B Dec ’24
Risk Factors
- • Newly added trade dispute risk triggered by U.S. tariffs on imports from Canada, Mexico, China impacting DuPont's global supply and product competitiveness
- • Materially updated regulatory risk from SAMR's April 2025 antitrust investigation suspension related to Tyvek®, $90M sales in China in 2024
Quarterly Financial SummaryXBRL
Revenue
$3.3B
▲ +2.7% YoY▲ +6.2% QoQ
Net Income
$59M
▼ -66.9% YoY▲ +110.0% QoQ
Net Margin
1.8%
▼ -380bp YoY▲ +2102bp QoQ
EPS (Diluted)
$0.14
▼ -66.7% YoY▲ +109.9% QoQ
Operating Cash Flow
$381M
▼ -27.7% YoY▼ -0.3% QoQ
Source: XBRL data from DuPont Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other DuPont Quarterly Reports
Get deeper insights on DuPont
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.